Clinical trial
mRNA Expression in Lymphocytes of Glaucoma Patients
NCT00327509 · University Hospital, Basel, Switzerland, Other · Completed
Key facts
| NCT number | NCT00327509 |
|---|---|
| Title | mRNA Expression in Lymphocytes of Glaucoma Patients |
| Official title | Messenger Ribonucleic Acid Expression in Lymphocytes of Glaucoma Patients |
| Lead sponsor | University Hospital, Basel, Switzerland, Other |
| Collaborators | University of Bonn |
| Status | Completed |
| Study type | Observational |
| Conditions | Glaucoma, Healthy Subjects |
| Enrollment | 60 |
| Start date | Jan 1, 2004 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | May 18, 2006 |
| Last update posted | Aug 20, 2009 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: